Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lamparelli

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|June 26, 2007
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplantD Vicente, T Lamparelli, F Gualandi, et al.
British Journal of Haematology|August 6, 2000
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of ageA M Raiola, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|June 6, 2006
Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortalityD Vicente, M Podestà, A Pitto, et al.
Bone Marrow Transplantation|September 22, 1999
Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubinA Bacigalupo, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|July 9, 2009
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplantsA Bacigalupo, T Lamparelli, G Milone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplantsA Bacigalupo, T Lamparelli, F Gualandi, et al.
Bone Marrow Transplantation|May 1, 1997
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantationA Bacigalupo, M Soracco, F Vassallo, et al.
Bone Marrow Transplantation|October 14, 2014
DLI after haploidentical BMT with post-transplant CYA Ghiso, A M Raiola, F Gualandi, et al.
Bone Marrow Transplantation|April 15, 2003
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusionsA M Raiola, M T Van Lint, M Valbonesi, et al.
Bone Marrow Transplantation|June 4, 2015
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an updateA Bacigalupo, A Dominietto, A Ghiso, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|June 26, 2007
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplantD Vicente, T Lamparelli, F Gualandi, et al.
British Journal of Haematology|August 6, 2000
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of ageA M Raiola, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|June 6, 2006
Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortalityD Vicente, M Podestà, A Pitto, et al.
Bone Marrow Transplantation|September 22, 1999
Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubinA Bacigalupo, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|July 9, 2009
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplantsA Bacigalupo, T Lamparelli, G Milone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplantsA Bacigalupo, T Lamparelli, F Gualandi, et al.
Bone Marrow Transplantation|May 1, 1997
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantationA Bacigalupo, M Soracco, F Vassallo, et al.
Bone Marrow Transplantation|October 14, 2014
DLI after haploidentical BMT with post-transplant CYA Ghiso, A M Raiola, F Gualandi, et al.
Bone Marrow Transplantation|April 15, 2003
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusionsA M Raiola, M T Van Lint, M Valbonesi, et al.
Bone Marrow Transplantation|June 4, 2015
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an updateA Bacigalupo, A Dominietto, A Ghiso, et al.
Pageof 7